Effect of nucleoside reverse transcriptase inhibitors on innate immune priming

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-510378-14-00

Acronym

PHARM-202202

Enrollment

Registered

2024-05-08

Start date

2024-06-20

Completion date

Unknown

Last updated

2024-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

modulation of the innate immune system in healthy subjects

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026